Cargando…
Two Year Visual Acuity and Structural Outcomes in Patients with Diabetic Macular Oedema Treated with Intravitreal Aflibercept – A Retrospective Cohort Study
PURPOSE: To assess visual and anatomical outcomes of intravitreal aflibercept for clinically significant diabetic macular oedema (DME). METHODS: For this retrospective single-center cohort study at a tertiary referral center, we performed a data warehouse query to identify 117 treatment-naive patien...
Autores principales: | Kern, Christoph, Schiefelbein, Johannes, Fu, Dun Jack, Schworm, Benedikt, Sim, Dawn, Herold, Tina, Priglinger, Siegfried, Kortuem, Karsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049742/ https://www.ncbi.nlm.nih.gov/pubmed/32161438 http://dx.doi.org/10.2147/OPTH.S237586 |
Ejemplares similares
-
Big data simulations for capacity improvement in a general ophthalmology clinic
por: Kern, Christoph, et al.
Publicado: (2021) -
Ranibizumab non-response in pachychoroid neovasculopathy: Effects of switching to aflibercept
por: Schworm, Benedikt, et al.
Publicado: (2020) -
Intravitreal aflibercept for treatment of macular oedema associated with immune recovery uveitis
por: Rothova, Aniki, et al.
Publicado: (2020) -
Risk of transient vision loss after intravitreal aflibercept using vial-prepared vs. the novel prefilled syringe formulation
por: Klaas, Julian E., et al.
Publicado: (2023) -
Evaluation of Functional Outcomes and OCT-Biomarkers after Intravitreal Dexamethasone Implant for Postoperative Cystoid Macular Edema in Vitrectomized Eyes
por: Freissinger, Sigrid, et al.
Publicado: (2020)